What are the key takeaways from SGRY's 2024 earnings trend?

**Surgery Partners Inc. (SGRY) demonstrated strong performance in 2024**, with key takeaways including: 1. **Revenue Growth**: SGRY achieved a significant increase in total revenues, reaching $3.1 billion for the fiscal year ended December 31, 2024, up from $2.7 billion in the previous year. This growth was primarily driven by same-facility revenue growth and acquisitions completed in 2024. 2. **Cost Management**: The company reported a cost of revenues for the year of $2,368.7 million, which represented 76.1% of revenues. This indicates efficient cost management, as the cost ratio remained stable at 76.4% in the previous year. 3. **Financial Performance**: SGRY reported a net loss attributable to Surgery Partners, Inc. of $168.1 million for the year, compared to a net loss of $11.9 million in the previous year. Despite the net loss, the company showed improvement in profitability, with an increase in adjusted EBITDA to $508.2 million from $438.1 million in the previous year. 4. **Cash Flow**: The company generated cash from operating activities amounting to $300.1 million. However, there was a significant outflow in financing and investing activities, with $488.5 million and $262.0 million, respectively. This resulted in cash and cash equivalents of $269.5 million as of December 31, 2024. 5. **Earnings Beat Expectations**: In Q4 2024, SGRY surpassed analyst expectations with an EPS of $0.44 compared to the forecast of $0.39. The company also exceeded revenue forecasts, reporting $864.4 million instead of the anticipated $827.9 million. 6. **Stock Performance**: Despite the positive earnings results, the stock experienced a slight decline of 0.37% in the pre-market session, reflecting broader market conditions. Overall, SGRY's 2024 earnings trend reflects robust growth in revenues and profitability, with the company setting milestones in revenue and adjusted EBITDA. The strategic investments in high-acuity specialties and increased surgical cases have been instrumental in driving this growth.